Jeffrey is a skilled healthcare executive with substantial knowledge of regulatory advocacy and healthcare policies. Jeffrey’s work focuses on issues tied to provider payment and reimbursement as well as quality reporting. He also has significant experience with recent regulatory developments such as the implementation of surprise billing rules.
Prior to joining McDermott+, Jeffrey served as the director of regulatory and external affairs at the American College of Emergency Physicians (ACEP). In that role, Jeffrey managed ACEP’s formal response to federal policies and worked with federal agencies and other stakeholders to help advance ACEP’s federal affairs agenda.
Jeffrey also spent eight years working with the US Department of Health and Human Services, where he advised senior officials on major budgetary and policy considerations within Medicare and prepared detailed analyses of Medicare regulations and legislation.
Insights, News & Events
Washington, DC / National Journal / July 10, 2024
Supreme Court Rulings Portend Potential Shakeup of Health-agency Authorities
Washington, DC / Inside Health Policy / July 2, 2024
New Data on Surprises Act: Most Winning Offers Higher than QPA
Washington, DC / The Guardian / July 6, 2024
Chevron Doctrine Ruling a ‘Gut-punch’ for US Health and Environment – Experts
Washington, DC / Inside Health Policy / July 1, 2024
Cassidy to CMS: Strictly Follow No Surprises Act Statute Post Chevron
Washington, DC / Becker's Hospital Review / June 28, 2024
How the Supreme Court's Chevron Deference Ruling Could Affect Healthcare
Washington, DC / Inside Health Policy / June 17, 2024
Admin Creates Exception Period for No Surprises Act Negotiations Due to Change ...
Washington, DC / Bloomberg Law / June 13, 2024
Insurers Still Losing in Surprise Billing Arbitration, Data Show
Client alert / November 14, 2023
HHS Issues Provider Information Blocking Disincentives Proposed Rule
McDermott+Consulting +Insight / November 6, 2023
Washington, DC / Inside Health Policy / July 2, 2024
New Data on Surprises Act: Most Winning Offers Higher than QPA
Washington, DC / The Guardian / July 6, 2024
Chevron Doctrine Ruling a ‘Gut-punch’ for US Health and Environment – Experts
Washington, DC / Inside Health Policy / July 1, 2024
Cassidy to CMS: Strictly Follow No Surprises Act Statute Post Chevron
Washington, DC / Becker's Hospital Review / June 28, 2024
How the Supreme Court's Chevron Deference Ruling Could Affect Healthcare
Washington, DC / Inside Health Policy / June 17, 2024
Admin Creates Exception Period for No Surprises Act Negotiations Due to Change ...
Washington, DC / Bloomberg Law / June 13, 2024
Insurers Still Losing in Surprise Billing Arbitration, Data Show
Disclaimer
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.